Gene · 442908
Papers1,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression. | Cell Death Dis | 2023 | 37626035 | PubTator, text mining | PubMed |
| Cryotherapy Attenuates Inflammation via the lncRNA SNHG1/miR-9-5p/NFKB1 Regulatory Axis in Periodontal Ligament Cells. | Int J Mol Sci | 2023 | 37569472 | PubTator, text mining | PubMed |
| Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities. | Cancers (Basel) | 2023 | 37568815 | PubTator, text mining | PubMed |
| MicroRNA-325 targets lipocalin 15 to suppress proliferation, migration and invasion of breast cancer cells. | Arch Med Sci | 2023 | 37560715 | PubTator, text mining | PubMed |
| Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration. | J Biomed Sci | 2023 | 37550658 | PubTator, text mining | PubMed |
| Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients. | Front Oncol | 2023 | 37546401 | PubTator, text mining | PubMed |
| Mechanisms and applications of adipose-derived stem cell-extracellular vesicles in the inflammation of wound healing. | Front Immunol | 2023 | 37520532 | PubTator, text mining | PubMed |
| Therapeutic Potential of EVs: Targeting Cardiovascular Diseases. | Biomedicines | 2023 | 37509546 | PubTator, text mining | PubMed |
| Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease. | Front Aging Neurosci | 2023 | 37476007 | PubTator, text mining | PubMed |
| MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p. | J Bone Oncol | 2023 | 37457846 | PubTator, text mining | PubMed |
| The Effect of miR-140-5p with HDAC4 towards Growth and Differentiation Signaling of Chondrocytes in Thiram-Induced Tibial Dyschondroplasia. | Int J Mol Sci | 2023 | 37446153 | PubTator, text mining | PubMed |
| Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors. | Int J Mol Sci | 2023 | 37446039 | PubTator, text mining | PubMed |
| Comprehensive pan-cancer analysis identifies FHL2 associated with poor prognosis in lung adenocarcinoma. | Transl Cancer Res | 2023 | 37434686 | PubTator, text mining | PubMed |
| RUSC1-AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR-326/XRCC5 pathway. | Thorac Cancer | 2023 | 37429610 | PubTator, text mining | PubMed |
| A review on the role of CASC11 in cancers. | Front Cell Dev Biol | 2023 | 37427385 | PubTator, text mining | PubMed |
| Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma. | Front Oncol | 2023 | 37404761 | PubTator, text mining | PubMed |
| Extracellular Vesicles Derived from Mesenchymal Stem Cells as Cell-Free Therapy for Intrauterine Adhesion. | Int J Stem Cells | 2023 | 37385632 | PubTator, text mining | PubMed |
| The Effect of miR-4800 Restoration on Proliferation and Migration of Human Breast Cancer Cells In Vitro. | Adv Pharm Bull | 2023 | 37342379 | PubTator, text mining | PubMed |
| A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma. | Transl Cancer Res | 2023 | 37304536 | PubTator, text mining | PubMed |
| miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy. | Int J Mol Sci | 2023 | 37298143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442908/papers?page=5